Johnson & Johnson To Start Coronavirus Vaccine Human Trials Ahead Of Schedule In July

Johnson & Johnson JNJ will begin the human clinical trials of its novel coronavirus (COVID-19) vaccine in July, the company announced Wednesday.

What Happened

The human trials of the Johnson & Johnson COVID-19 vaccine were earlier expected to begin in September.

The pharmaceutical company said 1045 volunteers, in the age groups of 18 to 55 and above 65, will participate in the phase 1/2 clinical trials, which will evaluate the safety, reactogenicity, and immunogenicity of the vaccine candidate.

"Based on the strength of the preclinical data we have seen so far and interactions with the regulatory authorities, we have been able to further accelerate the clinical development of our investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant," Johnson & Johnson Chief Scientific Officer Paul Stoffels said in a statement.

Why It Matters

The New Jersey-based company's vaccine is one of the five candidates considered by President Donald Trump's "Operation Warp Speed" as most likely to get regulatory approval, the New York Times reported.

Other lead vaccine candidate developers include Moderna Inc. MRNA, Pfizer Inc. PFE, AstraZeneca plc AZN, and Merck & Co. Inc. MRK.

What's Next

Johnson & Johnson said it in discussion with the National Institutes of Allergy and Infectious Diseases to start the third phase of its clinical trials ahead of schedule as well, if phase one results are favorable, and it gets necessary regulatory approval.

The company said it is also increasing its manufacturing capacity and talking with partners globally "to ensure worldwide access" once and if the vaccine is approved for preventative use against the coronavirus.

JNJ Price Action

Johnson and Johnson's shares closed nearly 1.3% higher at $147.80 on Wednesday. The shares were unchanged in the after-hours session.

Posted In: Covid-19Donald TrumpPharma StocksThe New York TimesvaccineBiotechNewsFDAMediaGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.